These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34589364)

  • 41. Diffusion-weighted magnetic resonance imaging in monitoring rectal cancer response to neoadjuvant chemoradiotherapy.
    Barbaro B; Vitale R; Valentini V; Illuminati S; Vecchio FM; Rizzo G; Gambacorta MA; Coco C; Crucitti A; Persiani R; Sofo L; Bonomo L
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):594-9. PubMed ID: 22099033
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rectal Signet Ring Cell Carcinoma: Post-Chemoradiotherapy Evaluation by MRI and Corresponding to Pathology.
    Zhou Y; Li Q; Mao Y
    Front Surg; 2022; 9():841645. PubMed ID: 35310426
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Accuracy and Clinical Impact of Persistent Disease Diagnosed on Diffusion-Weighted Imaging and Accuracy of Pelvic Nodal Assessment on Magnetic Resonance Imaging for Squamous Cell Carcinoma of the Anus in the 6-Month Interval Post Chemoradiotherapy.
    Fernandes MC; Charbel C; Romesser PB; Ucpinar BA; Homsi ME; Yildirim O; Fuqua JL; Rodriguez LA; Zheng J; Capanu M; Gollub MJ; Horvat N
    Int J Radiat Oncol Biol Phys; 2024 Sep; 120(1):120-129. PubMed ID: 38462017
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multi-parametric magnetic resonance imaging assessment of whole tumour heterogeneity for chemoradiotherapy response prediction in rectal cancer.
    Pham TT; Liney G; Wong K; Henderson C; Rai R; Graham PL; Borok N; Truong MX; Lee M; Shin JS; Hudson M; Barton MB
    Phys Imaging Radiat Oncol; 2021 Apr; 18():26-33. PubMed ID: 34258404
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results.
    Lambrecht M; Vandecaveye V; De Keyzer F; Roels S; Penninckx F; Van Cutsem E; Filip C; Haustermans K
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):863-70. PubMed ID: 21398048
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessment of pathological complete response to preoperative chemoradiotherapy by means of multiple mathematical models of diffusion-weighted MRI in locally advanced rectal cancer: A prospective single-center study.
    Zhu HB; Zhang XY; Zhou XH; Li XT; Liu YL; Wang S; Sun YS
    J Magn Reson Imaging; 2017 Jul; 46(1):175-183. PubMed ID: 27981667
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diffusion and perfusion MR parameters to assess preoperative short-course radiotherapy response in locally advanced rectal cancer: a comparative explorative study among Standardized Index of Shape by DCE-MRI, intravoxel incoherent motion- and diffusion kurtosis imaging-derived parameters.
    Fusco R; Sansone M; Granata V; Grimm R; Pace U; Delrio P; Tatangelo F; Botti G; Avallone A; Pecori B; Petrillo A
    Abdom Radiol (NY); 2019 Nov; 44(11):3683-3700. PubMed ID: 30361867
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficiency of Non-Contrast-Enhanced Liver Imaging Sequences Added to Initial Rectal MRI in Rectal Cancer Patients.
    Kwon GH; Kim KA; Hwang SS; Park SY; Kim HA; Choi SY; Kim JW
    PLoS One; 2015; 10(9):e0137320. PubMed ID: 26348217
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Value of functional magnetic resonance imaging in predicting outcomes of neoadjuvant chemoradiotherapy in rectal cancer].
    Yu Y; Yue J; Yu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 May; 20(5):491-494. PubMed ID: 28534322
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of diffusion-weighted MRI and (18)F-FDG PET/CT in the prediction of pathologic complete response after radiochemotherapy for rectal cancer: a systematic review.
    Joye I; Deroose CM; Vandecaveye V; Haustermans K
    Radiother Oncol; 2014 Nov; 113(2):158-65. PubMed ID: 25483833
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 3.0 T MRI IVIM-DWI for predicting the efficacy of neoadjuvant chemoradiation for locally advanced rectal cancer.
    Hu H; Jiang H; Wang S; Jiang H; Zhao S; Pan W
    Abdom Radiol (NY); 2021 Jan; 46(1):134-143. PubMed ID: 32462386
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment of aggressiveness of rectal cancer using 3-T MRI: correlation between the apparent diffusion coefficient as a potential imaging biomarker and histologic prognostic factors.
    Akashi M; Nakahusa Y; Yakabe T; Egashira Y; Koga Y; Sumi K; Noshiro H; Irie H; Tokunaga O; Miyazaki K
    Acta Radiol; 2014 Jun; 55(5):524-31. PubMed ID: 24005562
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combined value of apparent diffusion coefficient-standardized uptake value max in evaluation of post-treated locally advanced rectal cancer.
    Ippolito D; Fior D; Trattenero C; Ponti ED; Drago S; Guerra L; Franzesi CT; Sironi S
    World J Radiol; 2015 Dec; 7(12):509-20. PubMed ID: 26753066
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Machine learning for prediction of chemoradiation therapy response in rectal cancer using pre-treatment and mid-radiation multi-parametric MRI.
    Shi L; Zhang Y; Nie K; Sun X; Niu T; Yue N; Kwong T; Chang P; Chow D; Chen JH; Su MY
    Magn Reson Imaging; 2019 Sep; 61():33-40. PubMed ID: 31059768
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Magnetic resonance imaging in rectal cancer downstaged using neoadjuvant chemoradiation: accuracy of prediction of tumour stage and circumferential resection margin status.
    Kulkarni T; Gollins S; Maw A; Hobson P; Byrne R; Widdowson D
    Colorectal Dis; 2008 Jun; 10(5):479-89. PubMed ID: 18318754
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Apparent diffusion coefficient as a non-invasive predictor of treatment response and recurrence in locally advanced rectal cancer.
    Elmi A; Hedgire SS; Covarrubias D; Abtahi SM; Hahn PF; Harisinghani M
    Clin Radiol; 2013 Oct; 68(10):e524-31. PubMed ID: 23830776
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The potential predictive value of MRI and PET-CT in mucinous and nonmucinous rectal cancer to identify patients at high risk of metastatic disease.
    Barbaro B; Leccisotti L; Vecchio FM; Di Matteo M; Serra T; Salsano M; Poscia A; Coco C; Persiani R; Alfieri S; Gambacorta MA; Valentini V; Giordano A; Bonomo L
    Br J Radiol; 2017 Jan; 90(1069):20150836. PubMed ID: 27845566
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Performance of diffusion-weighted imaging, perfusion imaging, and texture analysis in predicting tumoral response to neoadjuvant chemoradiotherapy in rectal cancer patients studied with 3T MR: initial experience.
    De Cecco CN; Ciolina M; Caruso D; Rengo M; Ganeshan B; Meinel FG; Musio D; De Felice F; Tombolini V; Laghi A
    Abdom Radiol (NY); 2016 Sep; 41(9):1728-35. PubMed ID: 27056748
    [TBL] [Abstract][Full Text] [Related]  

  • 59. T2-weighted signal intensity-selected volumetry for prediction of pathological complete response after preoperative chemoradiotherapy in locally advanced rectal cancer.
    Kim S; Han K; Seo N; Kim HJ; Kim MJ; Koom WS; Ahn JB; Lim JS
    Eur Radiol; 2018 Dec; 28(12):5231-5240. PubMed ID: 29858637
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quantitative Assessment of Rectal Cancer Response to Neoadjuvant Combined Chemotherapy and Radiation Therapy: Comparison of Three Methods of Positioning Region of Interest for ADC Measurements at Diffusion-weighted MR Imaging.
    Blazic IM; Lilic GB; Gajic MM
    Radiology; 2017 Feb; 282(2):418-428. PubMed ID: 27253423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.